Illimis Therapeutics has completed a Series B funding round, securing $42m to expedite the development of its Gas6-mediated Anti-Inflammatory Adaptor…
Read More »Therapeutics
Wedbush analyst Laura Chico lowered the firm’s price target on Edgewise Therapeutics (EWTX) to $35 from $40 and keeps an…
Read More »
Monopar Therapeutics Inc. (NASDAQ:MNPR) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds. On June 23, Chardan…
Read More »We recently published a list of Investors Are Dumping These 10 Stocks. In this article, we are going to take…
Read More »CRISPR Therapeutics AG (NASDAQ:CRSP) has entered a $95 million upfront partnership with China-based Sirius Therapeutics to co-develop an siRNA drug…
Read More »We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are…
Read More »We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article,…
Read More »Cathie Wood’s Bold Move: 8 Straight Days Of Buying Beam Therapeutics As Stock Soars 14% Cathie Wood is back in…
Read More »